Higher levels of LRRN1 expression promote tumor cell proliferation, inhibiting cell apoptosis, and play an important role in preserving pluripotency-related proteins through AKT phosphorylation [66–68], leading to a poor clinical outcome in gastric and brain cancer. This evidence concerns the gene AKT1 and brain cancer.